Targeted Oncology1d
FDA Grants Orphan Drug Designation to MB-105 for R/R T-Cell Lymphoma
MB-105, a first-in-class CD5-targeted CAR T-cell therapy, received FDA orphan drug designation for relapsed/refractory T-cell ...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (March Bio), an emerging clinical stage biotechnology company committed to combating ...
Pharmabiz22h
March Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma
Biosciences receives US FDA orphan drug designation for MB-105 to treat relapsed/refractory CD5-positive T-cell lymphoma: Houston Thursday, January 30, 2025, 17:00 Hrs [IST] ...
Mena FN3d
March Biosciences Receives FDA Orphan Drug Designation For MB-105, A First-In-Class CD5 CAR-T Cell Therapy, For T-Cell Lymphoma
“Beyond an important regulatory milestone, securing orphan drug designation for MB-105 from the FDA underscores the critical need for new therapeutic options for patients with T-cell lymphoma ...
AMBCrypto15h
Toncoin: 240K TON moved to exchanges – Should traders be worried?
Since Pavel Durov's arrest in August, TON has experienced a significant sell-off in price and tokens, though signs of ...
Gilgeous-Alexander delivers as NBA-leading Thunder fend off Trail Blazers
Shai Gilgeous-Alexander scored 33 points and the NBA-leading Oklahoma City Thunder beat the Portland Trail Blazers, 118-108, ...